NOVEL USES OF MAMMALIAN CTLA-8 AND RELATED REAGENTS
摘要
Compositions and methods for using CTLA-8 to treat an abnormal physiological condition in an individual. The methods comprise administering a therapeutically effective amount of CTLA-8 alone, or in combination with oth er therapeutic reagents; or a CTLA-8 antagonist.
申请公布号
CA2235951(C)
申请公布日期
2003.04.01
申请号
CA19962235951
申请日期
1996.10.23
申请人
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;SCHERING CORPORATION
